Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 31;11(12):e1005258.
doi: 10.1371/journal.ppat.1005258. eCollection 2015 Dec.

Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat

Laura M Filkins  1 , George A O'Toole  1
Affiliations
Review

Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat

Laura M Filkins et al. PLoS Pathog. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Cystic fibrosis lung infections are polymicrobial, complex, and challenging to treat.
The airways of patients with CF are colonized from various host (as indicated) and environmental (not depicted) sources. Patients subsequently develop chronic, polymicrobial infections composed of diverse bacterial, fungal, and viral organisms. These polymicrobial communities both influence and are impacted by their human host through complex, multifactorial interactions. As highlighted in the figure above and throughout this review, CF lung microbial communities encounter frequent antibiotic therapy, host immune factors, and an altered lung environment (including the presence of hypoxic [low oxygen] and anoxic [no oxygen] regions) throughout disease progression, all of which contribute to the development of chronic communities that often have decreased microbial diversity and are populated by organisms that have become highly adapted and resilient to treatment. The combination of diverse colonization sources, dynamic inter-domain interactions, microbial adaptation, environmental factors, and patient therapy mediates patient outcome. Eventually, chronic pulmonary infection culminates in a decline in lung function, which becomes most severe during pulmonary exacerbations and late stage disease progression. This steep decline in lung function ultimately leads to respiratory failure, the primary cause of morbidity and mortality in CF patients today [6]. Figure illustration and design copyright 2015 William Scavone and used with permission.
See this image and copyright information in PMC

References

    1. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548–3558. - PMC - PubMed
    1. Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, et al. (2014) The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros 13: 49–55. 10.1016/j.jcf.2013.06.004 - DOI - PubMed
    1. Madan JC, Koestler DC, Stanton BA, Davidson L, Moulton LA, et al. (2012) Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 3:e00251. - PMC - PubMed
    1. Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, et al. (2014) Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome 2: 40 10.1186/2049-2618-2-40 - DOI - PMC - PubMed
    1. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, et al. (2012) Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 109: 5809–5814. 10.1073/pnas.1120577109 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances